Tenascin in human papillomavirus associated lesions of the uterine cervix.
AUTOR(ES)
Pöllänen, R
RESUMO
The immunohistochemical expression of tenascin was studied in 80 morphologically diagnosed condylomas and cervical intraepithelial neoplasia (CIN) lesions. The results were compared with the human papillomavirus (HPV) DNA subtype, which was determined by HPV dot blot and in situ hybridisation. Tenascin mRNA synthesis was also determined in 10 selected cases by in situ hybridisation. No statistically significant association was found between tenascin expression and the degree of dysplasia or the HPV subtype. There was, however, a strong correlation between the extent of tenascin immunoreactivity and the degree of inflammation. Synthesis of tenascin mRNA was detected in basal keratinocytes and in fibroblasts by in situ hybridisation. The lack of association between the grade of CIN and tenascin expression precludes its use as a marker of premalignancy in CIN.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=500551Documentos Relacionados
- Human papillomavirus DNA in glandular lesions of the uterine cervix.
- Sexual behaviour of women with human papillomavirus (HPV) lesions of the uterine cervix.
- Coexistent chlamydial infections related to natural history of human papillomavirus lesions in uterine cervix.
- Immunophenotypes of lymphocytes in prospectively followed up human papillomavirus lesions of the cervix.
- Detection of integrated high risk human papillomavirus in adenoid cystic carcinoma of the uterine cervix.
